CSIMarket
 


Vectivbio Holding Ag  (VECT)
Other Ticker:  
 

Cumulative Vectivbio Holding Ag's Leverage Ratio for Trailing Twelve Months Period

VECT's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

VECT Leverage Ratio for Trailing Twelve Months Period

(Dec 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Equity Growth 83.94 % 83.94 % 83.94 % 83.94 % -
Y / Y Total Liabilities Growth 91.07 % 91.07 % 91.07 % 91.07 % -
Leverage Ratio for Trailing Twelve Months Period 0.18 0.18 0.18 0.18 0.18
Total Ranking # 533 # 525 # 548 # 567 # 547
Seq. Equity Growth 0 % 0 % 0 % 83.94 % 0 %
Seq. Total Liabilities Growth 0 % 0 % 0 % 91.07 % 0 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2022
On the trailing twelve months basis Due to debt repayement of 0% Vectivbio Holding Ag has not changed Leverage Ratio for Trailing Twelve Months Period in the IV. Quarter to 0.18, a new company low.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry 42 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Vectivbio Holding Ag. While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are VECT's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 43
Sector # 281
S&P 500 # 519


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.18 0.18 0.18
(Dec 31 2022)   (Dec 31 2021)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2022, within Biotechnology & Pharmaceuticals Industry Leverage Ratio for Trailing Twelve Months Period
Polarityte Inc   0.50 
Cellectis S a   0.48 
Cel sci Corporation  0.47 
Candel Therapeutics Inc   0.47 
Freeline Therapeutics Holdings Plc  0.46 
Neurocrine Biosciences Inc   0.45 
Denali Therapeutics Inc   0.45 
Kodiak Sciences Inc   0.45 
Bluebird Bio Inc   0.41 
Vericel Corporation  0.41 
Century Therapeutics inc   0.40 
Palisade Bio Inc   0.40 
Scholar Rock Holding Corp  0.40 
Old Ayala Inc   0.40 
Recursion Pharmaceuticals Inc   0.39 
Cyclo Therapeutics Inc   0.37 
Surface Oncology Inc   0.37 
Sqz Biotechnologies Company  0.36 
Ginkgo Bioworks Holdings Inc   0.36 
Gritstone Bio Inc   0.36 
Aligos Therapeutics Inc   0.34 
Arcellx Inc   0.34 
Renovacor Inc   0.34 
Repligen Corp  0.33 
C4 Therapeutics Inc   0.33 
Iteos Therapeutics Inc   0.32 
Vir Biotechnology Inc   0.31 
Finch Therapeutics Group Inc   0.30 
Black Diamond Therapeutics Inc   0.30 
Fate Therapeutics Inc   0.30 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com